One study of measles viruses engineered to express anti-CTLA-4 showed a better effect in controlling tumor growth, while the survival effects were similar between viruses expressing anti-CTLA-4 or anti-PD-L1 antibodies and the control group (143). This evidence concerns the gene CTLA4 and neoplasm.